SG11201408053TA - Mixture for the inhibition of melanin biosynthesis - Google Patents
Mixture for the inhibition of melanin biosynthesisInfo
- Publication number
- SG11201408053TA SG11201408053TA SG11201408053TA SG11201408053TA SG11201408053TA SG 11201408053T A SG11201408053T A SG 11201408053TA SG 11201408053T A SG11201408053T A SG 11201408053TA SG 11201408053T A SG11201408053T A SG 11201408053TA SG 11201408053T A SG11201408053T A SG 11201408053TA
- Authority
- SG
- Singapore
- Prior art keywords
- mixture
- skin
- inhibition
- melanin biosynthesis
- cosmetic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 230000005764 inhibitory process Effects 0.000 title abstract 3
- 230000008099 melanin synthesis Effects 0.000 title abstract 3
- 206010008570 Chloasma Diseases 0.000 abstract 2
- 208000003351 Melanosis Diseases 0.000 abstract 2
- 239000002537 cosmetic Substances 0.000 abstract 2
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 abstract 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 1
- 206010064127 Solar lentigo Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 229950006780 n-acetylglucosamine Drugs 0.000 abstract 1
- 238000009877 rendering Methods 0.000 abstract 1
- 230000009759 skin aging Effects 0.000 abstract 1
- 230000037303 wrinkles Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
MIXTURE FOR THE INHIBITION OF MELANIN BIOSYNTHESIS The present invention relates to a mixture comprising acetylglucosamine and 4-(l-phenylethyl)-l,3-benzenediol for use as a cosmetic and/or medicament, and par ticularly for the inhibition of melanin biosynthesis, and to a cosmetic and/or pharma- 5 ceutical formulation comprising such mixture a for the treatment of hyperpigmented lesions of the skin such as, for example but without limitation, lentigo solaris, age spots, melasma and chloasma, for rendering uniform the color of the skin, for counter acting the formation of free radicals, and for counteracting or preventing signs of skin aging such as wrinkles and lack of skin tone, and generally for improving the aesthet- 10 ic conditions of the skin. No illustrative drawing.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000092A ITBS20120092A1 (en) | 2012-06-04 | 2012-06-04 | MIXTURE FOR THE INHIBITION OF MELANIN BIOSYNTHESIS |
PCT/IB2013/054606 WO2013182996A1 (en) | 2012-06-04 | 2013-06-04 | Mixture for the inhibition of melanin biosynthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201408053TA true SG11201408053TA (en) | 2015-01-29 |
Family
ID=46758827
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201408053TA SG11201408053TA (en) | 2012-06-04 | 2013-06-04 | Mixture for the inhibition of melanin biosynthesis |
SG10201704303VA SG10201704303VA (en) | 2012-06-04 | 2013-06-04 | Mixture for the inhibition of melanin biosynthesis |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201704303VA SG10201704303VA (en) | 2012-06-04 | 2013-06-04 | Mixture for the inhibition of melanin biosynthesis |
Country Status (14)
Country | Link |
---|---|
US (1) | US20150110725A1 (en) |
EP (1) | EP2854783B1 (en) |
JP (1) | JP2015518877A (en) |
KR (1) | KR20150023544A (en) |
CN (1) | CN104507462A (en) |
EA (1) | EA030102B1 (en) |
ES (1) | ES2668848T3 (en) |
IN (1) | IN2014MN02468A (en) |
IT (1) | ITBS20120092A1 (en) |
MY (1) | MY169101A (en) |
PL (1) | PL2854783T3 (en) |
SG (2) | SG11201408053TA (en) |
TR (1) | TR201806726T4 (en) |
WO (1) | WO2013182996A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3026566C (en) * | 2016-06-30 | 2023-10-03 | Symrise Ag | Medicament and cosmetic composition comprising resorcinol derivatives |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002053448A (en) * | 2000-07-28 | 2002-02-19 | Pentapharm Ltd | Outdoor cosmetic |
DE10324566A1 (en) * | 2003-05-30 | 2004-12-16 | Symrise Gmbh & Co. Kg | Use of diphenylmethane derivatives as tyrosinase inhibitors |
US20090162305A1 (en) | 2006-01-05 | 2009-06-25 | Symrise Gmbh & Co. Kg | Formulations of low oil content comprising diphenylmethane derivatives |
CN101139288B (en) * | 2006-09-07 | 2011-06-15 | 黑龙江大学 | Method for preparating ethyl linoleate by catalysis of composite solid ultra-strong acid |
KR101362619B1 (en) * | 2008-02-20 | 2014-02-13 | 이엘씨 매니지먼트 엘엘씨 | Topical compositions and methods for whitening skin |
FR2939669B1 (en) * | 2008-12-17 | 2011-03-25 | Oreal | COSMETIC METHOD FOR CONTROLLING SKIN BLIND INDUCED BY UV RADIATION; Compositions. |
EP2661264B1 (en) * | 2011-01-07 | 2018-12-05 | Allergan, Inc. | Melanin modification compositions and methods of use |
-
2012
- 2012-06-04 IT IT000092A patent/ITBS20120092A1/en unknown
-
2013
- 2013-06-04 MY MYPI2014703654A patent/MY169101A/en unknown
- 2013-06-04 ES ES13739805.3T patent/ES2668848T3/en active Active
- 2013-06-04 SG SG11201408053TA patent/SG11201408053TA/en unknown
- 2013-06-04 EP EP13739805.3A patent/EP2854783B1/en active Active
- 2013-06-04 TR TR2018/06726T patent/TR201806726T4/en unknown
- 2013-06-04 EA EA201492153A patent/EA030102B1/en not_active IP Right Cessation
- 2013-06-04 SG SG10201704303VA patent/SG10201704303VA/en unknown
- 2013-06-04 WO PCT/IB2013/054606 patent/WO2013182996A1/en active Application Filing
- 2013-06-04 CN CN201380040108.7A patent/CN104507462A/en active Pending
- 2013-06-04 JP JP2015515632A patent/JP2015518877A/en active Pending
- 2013-06-04 US US14/405,371 patent/US20150110725A1/en not_active Abandoned
- 2013-06-04 KR KR20147036941A patent/KR20150023544A/en not_active Application Discontinuation
- 2013-06-04 PL PL13739805T patent/PL2854783T3/en unknown
-
2014
- 2014-12-04 IN IN2468MUN2014 patent/IN2014MN02468A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ITBS20120092A1 (en) | 2013-12-05 |
JP2015518877A (en) | 2015-07-06 |
IN2014MN02468A (en) | 2015-07-10 |
ES2668848T3 (en) | 2018-05-22 |
MY169101A (en) | 2019-02-18 |
EP2854783A1 (en) | 2015-04-08 |
EA201492153A1 (en) | 2015-05-29 |
WO2013182996A1 (en) | 2013-12-12 |
SG10201704303VA (en) | 2017-07-28 |
PL2854783T3 (en) | 2018-08-31 |
EA030102B1 (en) | 2018-06-29 |
KR20150023544A (en) | 2015-03-05 |
CN104507462A (en) | 2015-04-08 |
US20150110725A1 (en) | 2015-04-23 |
EP2854783B1 (en) | 2018-02-14 |
TR201806726T4 (en) | 2018-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010083368A3 (en) | Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions | |
PH12015501806B1 (en) | Novel benzopyran kinase modulators | |
WO2012108689A3 (en) | Novel compound having skin-whitening, anti-oxidizing and ppar activities and medical use therefor | |
MX339820B (en) | Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1. | |
WO2010065662A3 (en) | Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1 | |
EP2193785A3 (en) | Extracts of Tetraselmis sp. for cosmetic and therapeutic purposes | |
MX352412B (en) | Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo. | |
BR112013002216A2 (en) | "use of roasted coffee beans to regulate skin pigmentation" | |
BR112013002215A2 (en) | use of green coffee beans to regulate skin pigmentation disorders | |
EP2558102A4 (en) | Synergistic interaction of at least one vitamin e component and tyrosinase inhibitors for dermatological applications | |
BR112012032877A2 (en) | use of chicoric acid and derivatives for skin pigmentation regulation | |
WO2012108677A3 (en) | Novel compound having skin-whitening, anti-oxidizing and ppar activities and medical use therefor | |
IN2014DN08921A (en) | ||
WO2011034962A3 (en) | Compounds that modulate intracellular calcium | |
CA2899814A1 (en) | Methods of skin whitening by use of canola extracts | |
WO2009112653A3 (en) | Cosmetic and/or dermatological composition | |
MX2015008783A (en) | Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one specific amide compound. | |
MY161419A (en) | Skin collagen production-promoting agent | |
MX2015009054A (en) | Cosmetic or dermatological composition comprising a merocyanine, an oily phase and a c1-c4 monoalkanol. | |
MX2014003449A (en) | Heterocyclocarbonylaminothiazoles, cosmetic or dermatological preparations containing said heterocyclocarbonylaminothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin. | |
PH12017501200A1 (en) | A skin lightening composition comprising niacinamide and ilomastat | |
SG11201408053TA (en) | Mixture for the inhibition of melanin biosynthesis | |
BR112012033090A2 (en) | use of kapharic acid and derivatives in food supplement for regulation of skin pigmentation | |
WO2018150395A4 (en) | 4-n-butylresorcinol preparations | |
TN2011000554A1 (en) | Use of delta-tocopheryl-carbohydrate as a depigmenting agent |